HDAC9 and neoplasm: As a novel HDAC inhibitor, chidamide triggers G0/G1 cell cycle arrest cell cycle inhibition and apoptosis in tumor cells by enhancing the expression levels of CDK inhibitors and DR6-related apoptotic genes (4).